LRCX Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
6.7B
+15.1%
5.8B
+9.3%
5.3B
+0.4%
5.3B
+3.0%
5.2B
Cost of Revenue
3.2B
+10.7%
2.9B
+8.8%
2.7B
+2.1%
2.6B
+2.2%
2.6B
Gross Profit
3.5B
+19.5%
2.9B
+9.8%
2.7B
-1.3%
2.7B
+3.7%
2.6B
Operating Expenses
965.3M
+11.8%
863.5M
+2.7%
841.0M
-1.7%
855.8M
+0.8%
848.6M
R&D
642.9M
+10.2%
583.2M
+1.7%
573.3M
-0.5%
576.4M
-0.6%
580.2M
SG&A
322.3M
+15.0%
280.3M
+4.7%
267.7M
-4.2%
279.3M
+4.1%
268.4M
Operating Income
2.5B
+22.8%
2.0B
+13.1%
1.8B
-1.0%
1.8B
+5.1%
1.7B
EBITDA
2.6B
+21.7%
2.2B
+13.0%
1.9B
-0.9%
1.9B
+5.0%
1.8B
Net Income
2.3B
+24.8%
1.8B
+14.5%
1.6B
+1.6%
1.6B
-8.8%
1.7B
EPS (Basic)
$1.82
+24.7%
$1.46
+15.0%
$1.27
+2.4%
$1.24
-8.1%
$1.35
EPS (Diluted)
$1.81
+24.8%
$1.45
+15.1%
$1.26
+1.6%
$1.24
-8.1%
$1.35
Shares (Diluted)
1.3B
-0.1%
1.3B
-0.3%
1.3B
-0.6%
1.3B
-0.6%
1.3B
Lam Research (LRCX) โ€” Financials